PSIL Stock: Earnings, Dividends & Analyst Estimates

Company Overview:

Market Cap: $23.19M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $15.63 - $27.02

5 Year PSIL Performance Metrics:

Total Return (with DRIP): -73.2% (-23.14% CAGR)

Total Return (no DRIP): -74.2% (-23.75% CAGR)

Share Price: -77.1% (-25.50% CAGR)

Yield on Cost (with DRIP): 3.95%

Total Invested: $10,000

Total Value (with DRIP): $2,683

Total Return $ (with DRIP): -$7,317

Dividend Increase: -93.3% (-56.66% CAGR)

Dividend Yield (FWD): 14.71% ($3.37)

PSIL 5-yr Total Return ($10K invested)

1M 3M 6M YTD 1Y 3Y 5Y 10Y

PSIL Share Price

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

PSIL Price CAGR:1Y: 19.83%2Y: 73.13%5Y: -24.08%10Y: -25.35%

PSIL Dividend Payments & Yield

Dividend Payments & Yield

PSIL Dividend CAGR:1Y: -74.30%2Y: -53.00%5Y: -56.66%10Y: -56.66%

Annual Dividends (Total Paid Per Year)

Dividend Growth Year Over Year

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

PSIL Dividends Info:

Annual Dividend: $3.368

Forward Yield: 14.71%

Ex-Dividend Date: 2025-12-22

Lifetime Dividends / Share: $2.89

PSIL Dividend History: Dates, Payments & Yield list

Below is a schedule of all PSIL dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
12/22/2025	12/24/2025	$1.684	19.3%	18.99%	$17.74
09/22/2025	09/24/2025	$0.020	0.23%	0.21%	$18.75
06/23/2025	06/25/2025	$0.012	0.18%	0.17%	$14.12
03/21/2025	03/24/2025	$0.163	2.66%	2.63%	$12.42
12/23/2024	12/25/2024	$0.055	1.06%	1.05%	$10.52
09/23/2024	09/25/2024	$0.109	2.75%	2.71%	$8.01
09/25/2023	09/27/2023	$0.300	3.47%	3.64%	$16.50
09/26/2022	09/30/2022	$0.542	8.05%	7.69%	$28.20

Projected Future Returns & Dividends for PSIL

Based on past 5-year performance, here are PSIL growth metrics:

Share price CAGR of -25.5%
Dividend CAGR of -56.66%

Using PSIL CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	PSIL (DRIP)	PSIL - No DRIP
Current Price	$22.90	$22.90
Start Shares	436.68	436.68
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	614.89	436.68
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$1.21	$1.21
Total Dividends	$2,909	$2,595
Final Value	$741	$3,122

Estimated Future Value + Dividends - PSIL

NOTE: Above numbers are our estimate based on PSIL's Dividend and Price CAGR over past 5 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

Company Info

AdvisorShares Psychedelics ETF (PSIL) had its IPO on 2021-09-16, and is traded on AMEX stock exchange.

This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. The fund's primary holdings consist of publicly traded life sciences firms focused on psychedelic medical treatments, in addition to other businesses involved in the broader psychedelics sector. It is important to note that this fund maintains a concentrated, non-diversified portfolio.

PSIL website: http://advisorshares.com/etfs/psil